Advertisement

Topics

Trial death prompts FDA to stop study of Advaxis candidate

08:24 EDT 14 Mar 2018 | thePharmaLetter

Shares in Advaxis slumped over 10% yesterday as the I-O specialist revealed it had been forced to stop…

Original Article: Trial death prompts FDA to stop study of Advaxis candidate

NEXT ARTICLE

More From BioPortfolio on "Trial death prompts FDA to stop study of Advaxis candidate"

Advertisement
Quick Search
Advertisement
Advertisement